Baseline Only (BO), N = 253 | Repeated Measurements (RM), N = 191 | p-value | ||||
---|---|---|---|---|---|---|
Sex (female) | n (%) | 171 (68%) | 96 (50%) | <0.001 | ||
Age (years) | Median [IQR] | 83.0 [77.7, 88.8] | 82.0 [76.6, 87.9] | 0.31 | ||
CFS | 0.26 | |||||
Fit (CFS 1-3) | n (%) | 29 (12%) | 20 (10%) | |||
Mild to moderate (CFS 4-6) | n (%) | 95 (38%) | 87 (46%) | |||
Severe (CFS 7-9) | n (%) | 127 (51%) | 84 (44%) | |||
Frailty Index | Median [IQR] | 0.3 [0.3, 0.4] | 0.3 [0.3, 0.4] | 0.68 | ||
Multimorbidity | Median [IQR] | 4.0 [3.0, 6.0] | 4.0 [3.0, 6.0] | 0.57 | ||
Nr. of medications prior to admission | Median [IQR] | 11.0 [7.0, 14.0] | 10.0 [7.0, 14.0] | 0.62 | ||
EuroQol 5D | Median [IQR] | 0.4 [0.2, 0.7] | 0.4 [0.2, 0.6] | 0.38 | ||
Psychological well-being | Median [IQR] | 76.0 [60.0, 88.0] | 76.0 [60.0, 88.0] | 0.57 | ||
(i)ADL before admission | Median [IQR] | 24.0 [17.5, 30.5] | 24.0 [18.0, 30.0] | 0.98 | ||
(i)ADL at admission | Median [IQR] | 36.0 [28.0, 38.0] | 37.0 [30.0, 39.0] | 0.36 | ||
Treatment focus | 0.14 | |||||
Curative | n (%) | 40 (16%) | 36 (19%) | |||
Recovery-oriented care | n (%) | 183 (75%) | 145 (77%) | |||
Symptom-oriented care | n (%) | 22 (9.0%) | 8 (4.2%) | |||
Length of stay (days) | Median [IQR] | 7.0 [4.0, 11.0] | 9.0 [6.0, 13.0] | <0.001 | ||
Deceased during admission | n (%) | 10 (4.0%) | 5 (2.6%) | 0.60 | ||
Men, N = 82 | Women, N = 171 | Men, N = 95 | Women, N = 96 | |||
GSmax at baseline (kPa) | Median [IQR] | 46 [38, 55] | 33 [26, 44] | 48 [37, 59] | 34 [26, 45] | M: 0.47 W: 0.70 |
FR at baseline (s) | Median [IQR] | 26 [17, 41] | 25 [15, 36] | 24 [17, 32] | 19 [13, 32] | M: 0.20 W: 0.03 |
GW at baseline (kPa*s) | Median [IQR] | 1070 [670, 1485] | 621 [397, 1001] | 936 [619, 1166] | 458 [306, 1055] | M: 0.08 W: 0.30 |